SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-013132
Filing Date
2024-04-04
Accepted
2024-04-04 12:05:21
Documents
30
Period of Report
2024-04-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41155
2 ex99-1.htm EX-99.1 14697
3 ex99-1_001.jpg GRAPHIC 249612
4 ex99-1_002.jpg GRAPHIC 542255
5 ex99-1_003.jpg GRAPHIC 326032
6 ex99-1_004.jpg GRAPHIC 294231
7 ex99-1_005.jpg GRAPHIC 301589
8 ex99-1_006.jpg GRAPHIC 244541
9 ex99-1_007.jpg GRAPHIC 299172
10 ex99-1_008.jpg GRAPHIC 261529
11 ex99-1_009.jpg GRAPHIC 358149
12 ex99-1_010.jpg GRAPHIC 269778
13 ex99-1_011.jpg GRAPHIC 232191
14 ex99-1_012.jpg GRAPHIC 327219
15 ex99-1_013.jpg GRAPHIC 323954
16 ex99-1_014.jpg GRAPHIC 236326
17 ex99-1_015.jpg GRAPHIC 360849
18 ex99-1_016.jpg GRAPHIC 590030
  Complete submission text file 0001493152-24-013132.txt   7418079

Data Files

Seq Description Document Type Size
19 XBRL SCHEMA FILE pcsa-20240403.xsd EX-101.SCH 3060
20 XBRL LABEL FILE pcsa-20240403_lab.xml EX-101.LAB 34240
21 XBRL PRESENTATION FILE pcsa-20240403_pre.xml EX-101.PRE 22389
33 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3622
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 24822228
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)